Topical Tacrolimus in Vernal Keratoconjunctivitis

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The main aim of this study is to evaluate the efficacy and safety of topical tacrolimus 0.01% eyedrops in patients with vernal keratoconjunctivitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Eye Center and The Eye Foundation for Research in Ophthalmology
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• with bilateral symmetrical palpebral and limbal vernal keratoconjunctivitis

• Patients 6-18 years of age

Exclusion Criteria:

• Pregnant patients

• Patients on systemic therapy for other allergic disorders

• Patients who cannot come for follow-up

• Patients who are on other topical medications for other comorbid ocular conditions